Skip to main content

Year: 2024

Theriva™ Biologics Reports Third Quarter 2024 Operational Highlights and Financial Results

Target patient enrollment of 92 evaluable patients achieved in the VIRAGE Phase 2b clinical trial of VCN-01 in patients with metastatic pancreatic ductal adenocarcinoma Manufacturing funding awarded by the Spanish Government’s National Knowledge Transfer Program Data and Safety Monitoring Committee Review of Phase 1b/2a SYN-004 in allogeneic hematopoietic cell transplant recipients recommends expansion to Cohort 3 Orphan Medicinal Product Designation granted by the European Commission to VCN-01 for the treatment of retinoblastoma Rare Pediatric Disease Designation granted by the FDA for the treatment of retinoblastoma Placed Second in International Competition for Merck KGaA’s EMEA Advance Biotech Grant ROCKVILLE, Md., Nov. 12, 2024 (GLOBE NEWSWIRE) —  Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage...

Continue reading

Mustang Bio Receives Positive Listing Determination from Nasdaq

WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that by decision dated November 8, 2024, the Nasdaq Hearings Panel granted the Company’s request for an extension to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market, including the $1.00 bid price requirement through January 31, 2025 and the $2.5 million stockholders’ equity requirement through February 18, 2025. The Company is considering all available options that may enable it to timely evidence compliance with the continued listing criteria and maintain its listing on Nasdaq; however,...

Continue reading

Barnes & Noble College Announces Strategic Partnership with Syracuse University

BASKING RIDGE, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Barnes & Noble College (BNC), a Barnes & Noble Education, Inc. (NYSE: BNED) company, today announced it has entered into a partnership agreement with Syracuse University to manage all course materials, retail and e-commerce operations for the University’s Campus Store. Prior to the new partnership, the Campus Store and in-venue athletics retail were self-operated by the University. Barnes & Noble College will begin transitioning store operations in November and continue through the end of the calendar year. “We are excited to welcome Barnes & Noble College to Syracuse University and look forward to our partnership,” says John Papazoglou, Senior Vice President and Chief Operations Officer, Syracuse University. “Their expertise will be invaluable as the University...

Continue reading

Milestone Scientific Schedules Third Quarter 2024 Financial Results and Business Update Conference Call

ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments. The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or +1 973-528-0011 for international callers and by entering the access code: 169295. A webcast and replay of the call may be accessed at Webcast URL: https://www.webcaster4.com/Webcast/Page/2306/51651. An audio replay of the call will be available through Friday, November...

Continue reading

Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update

Company accelerated commercialization with significant new partnerships both in the U.S. and Europe ATLANTA, Nov. 12, 2024 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, announces financial results for the quarter ended September 30, 2024 and provides a corporate update. Corporate Highlights from 3Q 2024 to dateAnnounced partnership with Boston IVF, prominent network of fertility centers, to offer FemaSeed® Announced the onboarding of the first infertility medical clinic customers to offer FemaSeed infertility treatment to patients in California and Florida Announced strategic distribution partnerships for CE-marked products, including...

Continue reading

NY Times Best Selling Author and Reality Television Personality Stassi Schroeder Moves Stassi Podcast to PodcastOne (PODC) in Seven Figure Deal

Stassi Move Strengthens Platform’s Existing Female-Focused Slate of Programming 49th New Podcast Joining PodcastOne’s Platform in 2024, 189 Total Podcasts LOS ANGELES, Nov. 12, 2024 (GLOBE NEWSWIRE) — PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today the acquisition of the highly acclaimed Stassi podcast, hosted by bestselling author and reality television personality Stassi Schroeder in a multiyear seven figure deal. The podcast addition strengthens and grows PodcastOne’s existing commitment to providing engaging content tailored to women. On the Stassi podcast, Stassi shares candid stories, personal reflections, and her token commentary on everything from pop culture to relationships to style, and beyond. With each episode, listeners get an intimate glimpse...

Continue reading

AXIL Brands Launches ‘X Series’ Earplugs: The Ultimate Fusion of Design, Fit, and Performance

LOS ANGELES, Nov. 12, 2024 (GLOBE NEWSWIRE) — (GLOBE NEWSWIRE) – AXIL Brands, Inc. (“AXIL” or the “Company”) (NYSE American: AXIL), an emerging global consumer products company for AXIL® hearing protection and enhancement products and Reviv3® hair and skin care products, announces the launch of its latest innovation, the ‘X Series’ Earplugs. The ‘X Series’ is engineered to provide an unparalleled hearing protection experience while delivering comfort and style. It is designed for multi-faceted lifestyles where hearing protection is needed or the ability to maintain hearing while simultaneously protecting one’s hearing is needed. X Series earplugs will provide hearing protection for various lifestyles and activities, such as motorsports, concert goers, stadium events, sleeping, auditory overload sensitivity, air travel, hunting,...

Continue reading

Foresight Launches Six Advanced Stereoscopic Sensor Kits to Revolutionize Industrial and Automotive 3D Perception

Foresight’s new sensor kit portfolio, designed for serial production, empowers developers and manufacturers across diverse sectors, including automated special purpose vehicles, warehouse and logistics automation, drones, unmanned aerial vehicles, aviation, and autonomous vehicle applications. Ness Ziona, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in automotive vision systems, announced the launch of its advanced sensor kit portfolio: ScaleCam™ Vision, ScaleCam™ Thermal, and QuadSight® in various configurations. These cutting-edge sensor kits are engineered to enhance perception capabilities, meeting the stringent requirements for applications in industrial automation and autonomous mobility. We believe that this...

Continue reading

Dime Community Bancshares Announces Pricing of Common Stock Offering

HAUPPAUGE, N.Y., Nov. 12, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (Nasdaq: DCOM) (“Dime” or the “Company”), the parent company of Dime Community Bank, announced the pricing of a public offering of 3,906,250 shares of its common stock, $0.01 par value (the “Common Stock”), at a public offering price of $32.00 per share, for aggregate gross proceeds of $125 million. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 585,937 shares of Common Stock at the public offering price, less underwriting discounts and commissions. The Company expects to close the offering, subject to customary conditions, on or about November 13, 2024. Dime expects to use the net proceeds from this offering for general corporate purposes to support its continued organic growth, which may include,...

Continue reading

Navient Receives Champion of Board Diversity Recognition by The Forum of Executive Women

HERNDON, Va., Nov. 12, 2024 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI) has been recognized by The Forum of Executive Women as a Champion of Board Diversity. This award annually honors the top public companies in the Philadelphia region with boards comprised of at least 30% women. The Forum of Executive Women’s annual Women in Leadership Report, which will be released in November and is a collaboration with PwC, provides an annual examination on diversity in the boardrooms and executive suites of the top 100 public companies in the Philadelphia region. This year, a record number of Champions of Board Diversity will be recognized — with 46 companies receiving the designation, up from 37 organizations in the year prior. The Champions of Board Diversity will be celebrated at an event today, featuring a keynote by Mary Purk,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.